Order Article Reprints

Andorfer KEC, Zeman F, Koller M, Zeller J, Fischer R, Seebauer CT, Vielsmeier V, Bohr C, Kühnel TS. TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial. Pharmaceutics. 2022; 14(11):2335. https://doi.org/10.3390/pharmaceutics14112335

Andorfer, Kornelia E. C., Florian Zeman, Michael Koller, Judith Zeller, René Fischer, Caroline T. Seebauer, Veronika Vielsmeier, Christopher Bohr, and Thomas S. Kühnel. 2022. "TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial" Pharmaceutics 14, no. 11: 2335. https://doi.org/10.3390/pharmaceutics14112335

Andorfer, K. E. C., Zeman, F., Koller, M., Zeller, J., Fischer, R., Seebauer, C. T., Vielsmeier, V., Bohr, C., & Kühnel, T. S. (2022). TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)—A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial. Pharmaceutics, 14(11), 2335. https://doi.org/10.3390/pharmaceutics14112335